Text Size

  • Increase
  • Decrease
  • Normal

Current Size: 100%

What’s New and What’s Not in Drug Therapy – the 411 and Implications for Palliative Care

Title: What’s New and What’s Not in Drug Therapy – the 411 and Implications for Palliative Care with Mary Lynn McPherson, PharmD, BCPS, CPE        

CE/CME Offered:

CE/CME Credit Available: Nurse, Physician

Member Price:  $105
Non-Member Price:  $210.00

Payment Options:

Add to Cart without CE/CME
Add to Cart with Nurse CE
Add to Cart with Physician CME credit

Length: 1.0 hour

This session was originally presented by: Mary Lynn McPherson, PharmD, BCPS, CPE at NHPCO’s 2014 Virtual Conference ‘Hot Topics in Palliative Care’. Almost thirty "new molecular entities" were approved by the US Food and Drug Administration last year, and countless other medications were brought to market, received expanded indications, or were developed in a new dosage formulation. It is critically important that palliative care practitioners remain current on new drug trends, and develop an understanding for the implications of patients with advanced illnesses using these medications. This presentation will focus on new medications approved or brought to market in the past 12-18 months, and the implications for palliative care (e.g., utility, toxicity, monitoring, etc.).  Drug safety alerts also released recently by the FDA will be discussed, and their implications for end-of-life care.


  • List new drugs approved by the FDA in 2013-2014
  • Describe the approved indication, unapproved uses of the medication, common adverse effects and drug interactions for each drug
  • Describe the burden-to-benefit ratio and the role of the medication in caring for patients with advanced illness for each new medication approved in 2013 - 2014
  • Analyze important drug alerts released by the FDA (Drug Safety Alerts) and their relevance to drug therapies commonly used in palliative care patients
Subject Matter Expert:

Mary Lynn McPherson, PharmD, BCPS, CPE

Mary Lynn McPherson, PharmD, BCPS, CPE, Mary Lynn McPherson is Professor and Vice Chair in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy in Baltimore. She has maintained a practice in both hospice (local and national) and ambulatory care her entire career. At present, Dr. McPherson is the Director of Pharmacotherapy Services at UniversityCare Heritage Crossing in Baltimore where she works primarily with chronic pain patients and patients with diabetes mellitus. Dr. McPherson teaches extensively in the Doctor of Pharmacy curriculum on pain management and end of life care, including didactic and experiential content. She also developed one of the first and few palliative care pharmacy residencies in the U.S.

Dr. McPherson serves on the Board of the Hospice Network of Maryland and is also the President of the American Society of Pain Educators. McPherson is a Fellow in the American Society of Health-Systems Pharmacists, the American Pharmacists Association, the American Society of Consultant Pharmacists and the American Society of Pain Educators. She is Board Certified in Pharmacotherapy, a Certified Diabetes Educator and a Certified Pain Educator. She has received many honors for her work, including the American Pharmacists Association Distinguished Achievement Award in Specialized Practice, the Maryland Pharmacists Association Innovative Practice Award, and the Maryland Society of Health-Systems Pharmacists W. Purdum Lifetime Achievement Award. Dr. McPherson has received many awards for teaching including the Presidential Citation from the Hospice and Palliative Nurses Association, Professor of the Year many times from the School of Pharmacy, University of Maryland Baltimore Founder’s Week Teacher of the Year and the Robert Chalmers Distinguished Educator Award from the American Association of Colleges of Pharmacy. She has written four books, including “Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing,” and many book chapters and peer-reviewed articles on pain management, palliative care, and other topics.


Planners: Barbara L. Bouton, MA, FT, and Jennifer Kennedy,
MA, BSN, RN, have no relevant financial relationships to disclose.

Subject Matter Experts: Mary Lynn McPherson, PharmD, BCPS, CPE has no relevant financial relationships to disclose.

CE/CME Credit Hours:

Nurse:  1.0 Contact Hour
Physicians:  1.0 AMA PRA Category 1 Credits™

Completion: In order to complete this online activity, participants must view the course in its entirety, correctly answer all case studies and quiz/test questions (as appropriate) and complete the evaluation. You will have access to the course for 90 days from the date of purchase.
CE/CME Info:


Nurse: NHPCO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NHPCO designates this enduring material for a maximum of 1.0 contact hour. Nurses should claim only the contact hour commensurate with the extent of their participation in the activity. Accredited status by ANCC refers only to continuing nursing education and does not imply endorsement of any commercial product discussed in conjunction with this activity.


Physician: The National Hospice and Palliative Care Organization is accredited by the Accreditation Council for  Continuing Medical Education to provide continuing medical  education for physicians.

NHPCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 credit(s)™. Physicians should  claim only the credit commensurate with the extent of their  participation in the activity.

Course Release Date: 01/29/2015

Course Expiration Date:


System Requirements

Get Acrobat!
The Acrobat Reader is required to view many resources.

Get Flash!
The Flash plug-in is required to view case studies, activities, and course navigation.